Meriem Messaoudene was chosen by the Seerave Foundation, a philanthropic organization, and will receive $200,000 to continue her work on castalagin for two years. She traveled to Vienna last June to present her work to the Seerave Foundation.
“It was pretty incredible to be the only representative of a Canadian team among these American, Israeli, French and Dutch research groups. Only five other teams in the world have received funding and were present! With this grant, we will try to better understand the mechanisms of action of castalagin and how it manages to have a beneficial impact on the microbiome.”
To read the article, click here.
Francis Rodier wins the 2019 Excellence Award
23 January 2020
The Montreal Cancer Institute congratulates Francis Rodier, who won the 2019 Excellence Award – Scientific Contribution of the Year 2019 […]
Anne-Marie Mes-Masson receives an Award of Excellence
23 November 2022
Congratulations to Anne-Marie Mes-Masson for her Award of Excellence – University of Ottawa Graduate of the Year 2022. Inaugurated in […]